Big Pharma: Human Trials for Cannabis brain cancer treatment
On November the 11th 2013, GW Pharmaceuticals, (a UK pharmaceutical company currently operating under a government monopoly license to grow cannabis) announced that they will be conducting phase “1b/2a clinical